Approval · Notice of Compliance 5095 · 1995
DIARR-EZE: Notice of Compliance 5095
Issued November 29, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5095
- Date
- November 29, 1995
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Therapeutic class
- Antidiarrheal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIARR-EZE | 02192667 | Cancelled Post Market |
Medicinal ingredients
- LOPERAMIDE HCL 0.2 MG per ML